• About Pharmetheus
    • History
    • Mission & Values
    • Leadership
    • Scientific advisors
    • Our team
    • Social impact (CSR)
    • Contexts of use
      • Trial design and analysis
      • Program strategies and efficiences
      • Special/specific populations
      • Special considerations
      • Regulatory interactions
    • Pharmetheus Platforms
      • Model-Informed Drug Development
      • PBPK & PBBM
      • Pharmacometrics
      • QSP
    • Solutions
      • Milestone Analysis
      • Embedded Scientists
      • Expert Advice
      • Scientific Publication
    • Specific services
      • Model-Informed Bioequivalence 
& Biosimilarity
      • Accelerated submission
      • Concentration-QTc (C-QTc) modeling
      • Data-driven strategies for pediatric success
      • Training workshops
      • Publications
      • Case studies
      • Articles
    • Working with us
    • Open positions
    • Employee stories
    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Qing Xi Ooi supports clients with hands-on analysis and strategic advice

    Viviana Moroso brings scientific depth to quality control

    Viviana Moroso brings scientific depth to quality control

    Siv Jönsson develops Pharmetheus’s learning agenda

    Siv Jönsson develops Pharmetheus’s learning agenda

  • Events
  • News
  • Contact us
  1. Home
  2. Publications

Publications

Below we provide links to posters, white papers and scientific publications by Pharmetheus affiliates in chronological order. Please note that access to some publications may require a subscription.

Search publications

Publications

08.07.16

Population PKPD Analysis of CD4 and ACR Response after SC Administration of Tregalizumab to Patients with Rheumatoid Arthritis

Pharmacometrics

Rheumatology

Program strategies and efficiencies

PAGE 25 (2016) Abstr 5708.

Magnusson MO, Plan EL, Remy A, König M, Aigner S, Braun V, Zipp D, Zhou X, Wolter R, Schüttrumpf J, Wartenberg-Demand A, Dälken B, Rharbaoui F

08.07.16

Reproducible Reporting

Regulatory interactions

Program strategies and efficiencies

PAGE 25 (2016) Abstr 6075.

Magnusson MO, Jonsson EN

01.06.16

A Model-Based Longitudinal Meta-Analysis of FEV1 in Randomized COPD Trials

Pharmacometrics

Respiratory

Program strategies and efficiencies

Clin Pharmacol Ther. 2016 Mar;99(3):315-24.

Korell J, Martin SW, Karlsson MO, Ribbing J

01.04.16

Population Pharmacokinetics of Tanezumab in Phase 3 Clinical Trials for Osteoarthritis Pain

MIDD

Pharmacometrics

Rheumatology

Br J Clin Pharmacol. 2016 Apr;81(4):688-699.

Jonsson EN, Xie R, Marshall SF, Arends RH

01.03.16

Determinants for Physical Growth Patterns in Low- and Middle-Income Countries

Specific populations

Pharmacometrics

PAGE 25 (2016) Abstr 5844.

Jonsson EN, Nyberg J, Häggström J, Lifecycle Auxology & Neurocognitive Development team, representing the Healthy Birth, Growth and Development knowledge integration (HBGDki) community

01.10.15

Translational Modelling of Regular Human Insulin Pharmacokinetics and Glucose Dynamics in Minipig and Dog

MIDD

Endocrinology

Pharmacometrics

Metabolism

Program strategies and efficiencies

PAGE 24 (2015) Abstr 3490.

Visser SAG, Fancourt C, Valiathan C, Carballo-Jane E, Van Heek M, Bergstrand M, Karlsson MO, Kjellsson MC, Cho CR

01.10.15

A Bolus and Bolus Followed by Infusion Study of AZD3043, an Investigational Intravenous Drug for Sedation and Anesthesia: Safety and Pharmacodynamics in Healthy Male and Female Volunteers

Trial design and analysis

CNS

Anesth Analg. 2015 Oct 1;121(4):894-903.

Norberg Å, Koch P, Kanes SJ, Björnsson MA, Barassin S, Ahlén K, Kalman S

01.10.15

Population Pharmacokinetic Simulations of Two Paliperidone Palmitate Formulations

Pharmacometrics

CNS

Program strategies and efficiencies

PAGE 24 (2015) Abstr 3643.

Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A

1 …31323334

Related content

16cefda6ef73b7faa4df913b326b6999f7619968 (1)

Science & Services

b794ade33e3aa54f89dcdaa2b69d3f48b3f73e5f (1)

Latest news

4033665f49ccf946b5c8406d016bbcdc6e406076 (1)

People & Culture


Contact

Pharmetheus AB
Kungsängstull 4 

753 19 Uppsala, Sweden

Visiting address: 

Dragarbrunnsgatan 77, 5th floor

  • LinkedIn
  • YouTube
  • Science & Services
    • Contexts of use
    • Pharmetheus Platforms
    • Solutions
    • Specific services
    • Publications
    • Case studies
  • Quick links
    • About us
    • Events
    • News
    • Careers
    • Contact us
    • Newsletter

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Gasell 2017
Gasell 2020
Gasell 2021
Gasell 2022
Gasell 2023
Gasell 2024

Copyright © Pharmetheus AB 2026

  • Whistleblower
  • Privacy Policy
  • Cookie Policy